Gene editing investors may soon have one more stock to choose from. A gene-editing company called Metagenomi $MGX uses AI to discover novel CRISPR gene editing methods from nature and they're planning to have an IPO. We start by looking at all the current players according to the IPO S-1 filing, then describe what the ideal gene editing business model looks like. Then, we describe how MGX plans to compete against CRISPR CAS9 competitors like CRISPR Therapeutics and Intellia Therapeutics. Basically, they have better technology - a platform that uses AI to discover gene editing tools - and they believe the intellectual property constraints won't apply to them. Would be buy Metagenomi stock? How about we wait for the IPO to happen first ;) We list out some milestones for gene editing investors to watch and look at how we expect the company to progress. Seems like there's never been a better time to invest in gene editing, but it's anybody's game with all the external risks. And there can be more than one winner.
RESEARCH PIECES USED IN THIS VIDEO:
1. Revisiting the Three Biggest Gene Editing Stocks
[ Ссылка ]
2. Beam Therapeutics Stock: A Leader in Gene Editing Tech?
[ Ссылка ]
3. A Complete List of 27 Gene Editing Stocks
[ Ссылка ]
4. Prime Medicine Stock: A Gene Editing IPO
[ Ссылка ]
CHAPTERS:
00:27 The most exciting technology we cover
02:01 What is metagenomics?
02:42 What Metagenomi does
03:40 The idea gene editing business model
04:52 Gene editing companies to watch
07:39 The Metagenomi advantage
10:07 Metagenomi IPO financials
11:31 Will we buy this new gene editing stock?
ABOUT US:
This video is brought to you by Nanalyze, a media and research firm founded by finance professionals with decades of experience. We share insights about #DisruptiveTechnology #stocks in a language that is future-proof and easy to understand.
Read all the Nanalyze Premium articles you'd like for free! Sign up for a 30-day trial of our monthly subscription with no strings attached: [ Ссылка ]
DISCLAIMER: Our content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, along with independently researching and verifying, any information contained within our YouTube videos or on our website, whether for the purpose of making an investment or otherwise.
#GeneEditing
$BEAM
$CRSP
$NTLA
$MGX
#crispr
#techstocks
New Gene Editing Stock [Should We Buy?]
Теги
gene editinggene editing stockscrispr stockscrsp stockcrispr stockcrispr stock analysiscrisprbest crispr stockscrispr stock newscrispr stock predictionstop gene editing stocksbest gene editing stocksinvesting in gene editinggenome editing stocksgene editing stocks 2024gene editing IPOmetagenomimetagenomi ipogenome editingmgxmgx stockmgx ipoinvesting in crisprinvest in crisprnew gene editing technologycas9crispr cas9dna$mgx